Analyst Price Targets — OGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 27, 2026 8:27 pm | — | Piper Sandler | $14.00 | $13.18 | TheFly | Organon upgraded to Neutral from Underweight at Piper Sandler |
| April 10, 2026 3:02 pm | — | BNP Paribas | $12.00 | $8.69 | TheFly | Organon takeover offer could be $15 per share, says BNP Paribas |
| February 24, 2026 10:45 am | — | Barclays | $8.00 | $7.92 | TheFly | Organon price target raised to $8 from $7.50 at Barclays |
| December 8, 2025 9:26 pm | — | Barclays | $7.50 | $7.29 | TheFly | Organon initiated with an Underweight at Barclays |
| October 27, 2025 2:55 pm | David Amsellem | Piper Sandler | $5.00 | $7.13 | TheFly | Piper double downgrades Organon to Underweight after CEO resignation |
| May 15, 2025 10:42 am | David Amsellem | Piper Sandler | $18.00 | $8.77 | TheFly | Organon price target lowered to $18 from $24 at Piper Sandler |
| May 5, 2025 11:30 am | Terence Flynn | Morgan Stanley | $10.00 | $8.72 | TheFly | Organon price target lowered to $10 from $15 at Morgan Stanley |
| April 29, 2024 7:40 am | David Amsellem | Piper Sandler | $24.00 | $18.85 | StreetInsider | Organon & Co. (OGN) PT Raised to $24 at Piper Sandler |
| June 26, 2023 9:08 am | David Amsellem | Piper Sandler | $34.00 | $20.37 | Benzinga | Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for OGN

VANCOUVER, BC / ACCESS Newswire / September 2, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the acquisition of the Toro de Oro and El Gigante gold projects in Southwest Utah, USA. Project Highlights Two low-sulphidation epithermal targets located in caldera complexes of southwest Utah Toro de Oro is centered on an extensive footprint of steam cap alteration…

Bank of America Corp DE reduced its position in shares of Organon and Co. (NYSE: OGN) by 58.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 738,502 shares of the company's stock after selling 1,041,346 shares during the period. Bank of America

TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Women's Health Collective Canada (WHCC) and the Partnership for Women's Health Research Canada (PWHR), in partnership with GreenShield and supported by a charitable grant from Organon, have launched the Researching Information, Support, and Equity During the Menopause Transition in Canada (Can-RISE) Study. As the first national investigator-led study focused on Canadian…

Organon and Co. (NYSE: OGN - Get Free Report) reached a new 52-week high during trading on Tuesday. The stock traded as high as $13.76 and last traded at $13.7540, with a volume of 4583387 shares trading hands. The stock had previously closed at $13.75. Analyst Ratings Changes Several research firms have recently weighed in

VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce it has acquired a 2% Net Smelter Return ("NSR") royalty (the "Royalty") on the Haldane silver project in Yukon Territory, Canada. Haldane Royalty Highlights 1,2,3,4 Haldane is a high-grade silver project owned by Silver North Resources Ltd.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
